October 1, 2015 | The American venture capital firm Third Rock Ventures, Len Blavatnik’s Access Industries and a daughter company of Clal Biotechnology will invest $55 million in Neon Therapeutics. The investment will reportedly be used to help Neon Therapeutics complete its cancer immunotherapy. Clal Biotechnoloigy was founded in 1998 and is based out of Ramat Gan, Israel.
Related posts
Israel Invests Millions To Help AI Comprehend Hebrew, Arabic
September 21, 2023
Cybersecurity Startup Cato Raises $238M With $3B Valuation
September 21, 2023
Israel, UK Ink Deal For Greater Innovation Collaboration
September 21, 2023
ALS Drug Receives Patent In Israel, Europe, Japan
September 20, 2023
Facebook comments